XML 31 R21.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stockholders' Equity
 9 Months Ended
Sep. 30, 2022
Equity [Abstract]  
Stockholders' Equity STOCKHOLDERS’ EQUITY
Accumulated other comprehensive income (loss)
The change in accumulated other comprehensive income (loss) related to our interest rate derivatives, net of taxes, was as follows (in thousands):
Three months ended September 30,Nine months ended September 30,
2022202120222021
Accumulated gain/(loss) at beginning of period$28,034 $(2,293)$(227)$(8,763)
Unrealized gains in fair value13,547 691 40,577 5,960 
Reclassifications of realized net losses to earnings832 601 2,063 1,802 
Accumulated gain/(loss) at end of period42,413 (1,001)42,413 (1,001)
The reclassifications of realized net losses to earnings in the above table are recorded within interest expense, net.
Share repurchases
During the three months ended September 30, 2022 we repurchased approximately 142 thousand shares of our common stock with an aggregate price of approximately $12.5 million, or $88.27 average price per share. During the nine months ended September 30, 2022 we repurchased approximately 1.2 million shares of our common stock with an aggregate price of approximately $112.2 million, or $92.98 average price per share. We did not repurchase any shares during the nine months ended September 30, 2021. On February 24, 2022, we announced that our board of directors authorized an extension of our previous stock repurchase program through March 1, 2023 and concurrently authorized an increase in the total amount of our
outstanding common stock we can purchase up to $200.0 million. On August 4, 2022, we announced that our board of directors authorized a new stock repurchase program which replaces our previous program. The new stock repurchase program allows for the repurchase of up to $200.0 million of our outstanding common stock through August 10, 2023. As of September 30, 2022, we had $187.5 million remaining on our new stock repurchase program. The effect of these treasury shares in reducing the number of common shares outstanding is reflected in our earnings per share calculation.
Dividends
During the nine months ended September 30, 2022, we declared and paid the following cash dividends (amount declared and amount paid in thousands):
Declaration DateRecord DatePayment DateDividend Per ShareAmount DeclaredAmount Paid
2/24/20223/15/20223/31/2022$0.90 $26,585 $26,242 
2/24/20223/15/20223/31/20220.315 9,305 9,184 
5/5/20226/15/20226/30/20220.315 9,054 8,982 
8/4/20229/15/20229/30/20220.315 9,018 8,945 
During the nine months ended September 30, 2021, we declared and paid the following cash dividends (amount declared and amount paid in thousands):
Declaration DateRecord DatePayment DateDividend Per ShareAmount DeclaredAmount Paid
2/23/20213/15/20213/31/2021$0.30 $8,907 $8,786 
5/5/20216/15/20216/30/20210.30 8,910 8,821 
8/5/20219/15/20219/30/20210.30 8,912 8,821 
The amount of dividends declared may vary from the amount of dividends paid in a period due to the vesting of restricted stock awards and performance share awards, which accrue dividend equivalent rights that are paid when the award vests. During the nine months ended September 30, 2022, we also paid $0.5 million in accrued dividends not included in the table above related to the vesting of these awards. The payment of future dividends will be at the discretion of our board of directors and will depend on our future earnings, capital requirements, financial condition, future prospects, results of operations, contractual restrictions, legal requirements, and other factors deemed relevant by our board of directors.